too risky to try that right now...yes agreed.
"Geron touts early stage cancer drug
Geron (NASDAQ: GERN ) jumped 12% in after-hours trading yesterday after further details were released pertaining to the company's early stage trial for imetelstat as a treatment for myelofibrosis, a type of bone marrow cancer. Data from the study are set to be presented at the American Society for Hematology meeting on Monday. Consequently, the FULL results are under a media embargo until they are formally presented at the meeting.
According to the TEASER released yesterday, patients taking imetelstat showed dramatic improvements at both the anatomical and molecular levels. But what really got investors' blood boiling was the handful of complete responses observed in the study, which is a first for this type of cancer."
anyone selling this stock now is INSANE. Just sit and enjoy the ride. Most likely well over double this time next year. Patients are awaiting approval and will go on immediately. Sales will be beyond expected numbers.
my thought is WAY oversold and RSI WAY below 20. You sell now you loose. Goes up from here. Has to...right?
me too...sick about this but put it all in prospective...all the good things in our life are still in place.